1. Home
  2. TENX vs SGLY Comparison

TENX vs SGLY Comparison

Compare TENX & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • SGLY
  • Stock Information
  • Founded
  • TENX 1967
  • SGLY 2001
  • Country
  • TENX United States
  • SGLY United States
  • Employees
  • TENX N/A
  • SGLY N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • TENX Health Care
  • SGLY
  • Exchange
  • TENX Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • TENX 19.5M
  • SGLY 5.8M
  • IPO Year
  • TENX N/A
  • SGLY 2008
  • Fundamental
  • Price
  • TENX $5.61
  • SGLY $1.55
  • Analyst Decision
  • TENX Strong Buy
  • SGLY
  • Analyst Count
  • TENX 4
  • SGLY 0
  • Target Price
  • TENX $20.67
  • SGLY N/A
  • AVG Volume (30 Days)
  • TENX 67.9K
  • SGLY 14.2K
  • Earning Date
  • TENX 11-13-2024
  • SGLY 11-14-2024
  • Dividend Yield
  • TENX N/A
  • SGLY N/A
  • EPS Growth
  • TENX N/A
  • SGLY N/A
  • EPS
  • TENX N/A
  • SGLY N/A
  • Revenue
  • TENX N/A
  • SGLY $2,742,157.00
  • Revenue This Year
  • TENX N/A
  • SGLY N/A
  • Revenue Next Year
  • TENX N/A
  • SGLY N/A
  • P/E Ratio
  • TENX N/A
  • SGLY N/A
  • Revenue Growth
  • TENX N/A
  • SGLY N/A
  • 52 Week Low
  • TENX $2.77
  • SGLY $1.27
  • 52 Week High
  • TENX $27.36
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.30
  • SGLY 43.10
  • Support Level
  • TENX $5.70
  • SGLY $1.58
  • Resistance Level
  • TENX $6.01
  • SGLY $1.71
  • Average True Range (ATR)
  • TENX 0.47
  • SGLY 0.09
  • MACD
  • TENX -0.08
  • SGLY -0.00
  • Stochastic Oscillator
  • TENX 12.15
  • SGLY 35.71

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: